Relative roles of genetic background and variation in PspA in the ability of antibodies to PspA to protect against capsular type 3 and 4 strains of Streptococcus pneumoniae
about
Discovery of a novel class of highly conserved vaccine antigens using genomic scale antigenic fingerprinting of pneumococcus with human antibodiesMonitoring the long-term molecular epidemiology of the pneumococcus and detection of potential 'vaccine escape' strains.Interaction of pneumococcal histidine triad proteins with human complement.Mucosal immunization with an unadjuvanted vaccine that targets Streptococcus pneumoniae PspA to human Fcγ receptor type I protects against pneumococcal infection through complement- and lactoferrin-mediated bactericidal activity.Active Immunization with Pneumolysin versus 23-Valent Polysaccharide Vaccine for Streptococcus pneumoniae KeratitisPspA family distribution, unlike capsular serotype, remains unaltered following introduction of the heptavalent pneumococcal conjugate vaccine.The Asd(+)-DadB(+) dual-plasmid system offers a novel means to deliver multiple protective antigens by a recombinant attenuated Salmonella vaccineFusion proteins containing family 1 and family 2 PspA fragments elicit protection against Streptococcus pneumoniae that correlates with antibody-mediated enhancement of complement deposition.Pneumococcal virulence gene expression and host cytokine profiles during pathogenesis of invasive disease.Pneumococcal surface protein A inhibits complement deposition on the pneumococcal surface by competing with the binding of C-reactive protein to cell-surface phosphocholineDevelopment of antibodies to PspA families 1 and 2 in children after exposure to Streptococcus pneumoniaeDistribution of pneumococcal surface protein A families 1 and 2 among Streptococcus pneumoniae isolates from children in finland who had acute otitis media or were nasopharyngeal carriers.Directed vaccination against pneumococcal disease.In situ pneumococcal vaccine production and delivery through a hybrid biological-biomaterial vector.Pneumococcal surface protein A contributes to secondary Streptococcus pneumoniae infection after influenza virus infection.Invasive and noninvasive Streptococcus pneumoniae capsule and surface protein diversity following the use of a conjugate vaccineStreptococcus pneumoniae surface protein PcpA elicits protection against lung infection and fatal sepsisIdentification of proteins in Streptococcus pneumoniae by reverse vaccinology and genetic diversity of these proteins in clinical isolates.The proline-rich region of pneumococcal surface proteins A and C contains surface-accessible epitopes common to all pneumococci and elicits antibody-mediated protection against sepsis.Relationship between surface accessibility for PpmA, PsaA, and PspA and antibody-mediated immunity to systemic infection by Streptococcus pneumoniae.Vaccine-induced human antibodies to PspA augment complement C3 deposition on Streptococcus pneumoniae.Distribution and genetic diversity of the ABC transporter lipoproteins PiuA and PiaA within Streptococcus pneumoniae and related streptococci.
P2860
Q33312893-D76AE3BF-B044-4657-A99C-8C56FC65AB3DQ33802910-1DEA8B2A-1A9A-4FF4-909F-198559FA8C55Q33826119-5B10D1D7-2126-4CE4-AC0C-A0F1C150F150Q35805480-9B6C3EF4-115E-4663-8BD6-08730959BDE7Q35826641-EBE39C9D-F729-40DD-AB62-E925E92E6B92Q36017785-A1372157-ABC5-4CB1-BC8A-5BA218BCEBEDQ36277335-1EBB534D-71DD-4D22-9387-F26352E47E9BQ36314000-735BC741-7AFD-47EF-ABE5-BD13C923918EQ36421548-444EE25E-59A8-43E2-B102-B82C085EFD1AQ36454995-0FFCDAC2-380C-4C4A-863E-80538FE76CA9Q36933011-B345CBE2-657A-40DD-915C-C907D349768CQ36933015-43762914-1C91-42E1-8FF2-D15F303A4B9EQ37040681-7A902E8F-1501-4B89-8367-5D75D431A094Q37088578-24CD03C2-8B57-45F1-A9DA-44D52F8A43C7Q37328278-AE9F6CF7-7B36-4507-BCBC-4DFBD2EF4A12Q37335485-43F0BF1D-5BC1-499A-BC9F-DF7BEAA9E133Q39023214-A7CA936D-9D92-49D5-872D-47F6297371A3Q39089994-717347E7-676F-4412-86A3-9BC4B6F91091Q40332317-8F69EC70-4EFC-4EA7-ACE3-C0D6EFF4E3D3Q41994055-DF5F3ED0-ABF9-44C4-8C7E-80E30A166EE4Q43078345-4A3A5377-2B8B-406E-B094-4CABE7F6A45DQ43182325-A19467FE-2A5B-4AB2-956C-762D65E19C84
P2860
Relative roles of genetic background and variation in PspA in the ability of antibodies to PspA to protect against capsular type 3 and 4 strains of Streptococcus pneumoniae
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Relative roles of genetic back ...... ns of Streptococcus pneumoniae
@ast
Relative roles of genetic back ...... ns of Streptococcus pneumoniae
@en
type
label
Relative roles of genetic back ...... ns of Streptococcus pneumoniae
@ast
Relative roles of genetic back ...... ns of Streptococcus pneumoniae
@en
prefLabel
Relative roles of genetic back ...... ns of Streptococcus pneumoniae
@ast
Relative roles of genetic back ...... ns of Streptococcus pneumoniae
@en
P2093
P2860
P1476
Relative roles of genetic back ...... ns of Streptococcus pneumoniae
@en
P2093
David E Briles
Hazeline Roche
Larry S McDaniel
P2860
P304
P356
10.1128/IAI.71.8.4498-4505.2003
P407
P577
2003-08-01T00:00:00Z